C. Yang

发表

Epothilone B enhances Class I HLA and HLA-A2 surface molecule expression in ovarian cancer cells.

S. Shahabi, G. Goldberg, I. Pellicciotta, 2011, Gynecologic oncology.

Low Concentrations of Taxol Cause Mitotic Delay Followed by Premature Dissociation of p55CDC from Mad2 and BubR1 and Abrogation of the Spindle checkpoint, Leading to Aneuploidy

Tomohiro Matsumoto, A. Ikui, S. Horwitz, 2005, Cell cycle.

Improved Dose-Response Relationship of (+)-Discodermolide-Taxol Hybrid Congeners.

Kenny Q. Ye, Amos B. Smith, S. Horwitz, 2018, Journal of natural products.

Taxol®: The First Microtubule Stabilizing Agent

S. Horwitz, C. Yang, 2017, International journal of molecular sciences.

Response to microtubule-interacting agents in primary epithelial ovarian cancer cells

S. Shahabi, G. Goldberg, I. Pellicciotta, 2013, Cancer Cell International.

A highly epothilone B–resistant A549 cell line with mutations in tubulin that confer drug dependence

F. Wang, S. Horwitz, G. Höfle, 2005, Molecular Cancer Therapeutics.

Distinct mechanisms of taxol-induced serine phosphorylation of the 66-kDa Shc isoform in A549 and RAW 264.7 cells.

S. Horwitz, C. Yang, 2002, Biochimica et biophysica acta.

Mutations in -Tubulin Map to Domains Involved in Regulation of Microtubule Stability in Epothilone- resistant Cell Lines

S. Horwitz, Lifeng He, C. Yang, 2001 .

MUTATIONS IN BETATUBULIN MAP TO DOMAINS INVOLVED IN REGULATION OF MICROTUBULE STABILITY IN EPOTHILONE-RESISTANT CELL LINES

S. Horwitz, Lifeng He, C. Yang, 2001 .

Reversal of the human and murine multidrug-resistance phenotype with megestrol acetate

P. Trail, S. Horwitz, A. Casazza, 2004, Cancer Chemotherapy and Pharmacology.

Wild-type class I beta-tubulin sensitizes Taxol-resistant breast adenocarcinoma cells harboring a beta-tubulin mutation.

S. Horwitz, C. Yang, Shujun Xia, 2007, Cancer letters.

Characterization of a human βV‐tubulin antibody and expression of this isotype in normal and malignant human tissue

Yihong Wang, S. Horwitz, A. Rodriguez-Gabin, 2012, Cytoskeleton.

Epothilone B enhances surface EpCAM expression in ovarian cancer Hey cells.

S. Horwitz, S. Shahabi, G. Goldberg, 2010, Gynecologic oncology.

Structural Basis of Microtubule Stabilization by Discodermolide

M. Steinmetz, M. Redondo-Horcajo, A. Prota, 2017, Chembiochem : a European journal of chemical biology.

Design and synthesis of (+)-discodermolide-paclitaxel hybrids leading to enhanced biological activity.

S. Horwitz, Amos B. Smith, Onur Atasoylu, 2011, Journal of medicinal chemistry.

Gene expression and mitotic exit induced by microtubule-stabilizing drugs.

M. Cammer, S. Horwitz, C. Yang, 2003, Cancer research.

Combined MEK and mTOR suppression is synergistic in human NSCLC and is mediated via inhibition of protein translation

S. Horwitz, H. McDaid, S. Keller, 2007 .

Termination of Protofilament Elongation by Eribulin Induces Lattice Defects that Promote Microtubule Catastrophes

M. Steinmetz, K. Jiang, A. Prota, 2016, Current Biology.

Wild-type class I β-tubulin sensitizes Taxol-resistant breast adenocarcinoma cells harboring a β-tubulin mutation

S. Horwitz, C. Yang, Shujun Xia, 2007 .

Vulnerability of ARID1A deficient cancer cells to pyrimidine synthesis blockade

Gloria S. Huang, Shijun Mi, Zhigui Li, 2020 .

Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of β-Tubulin and the Multidrug Resistance Associated P-Glycoprotein.

S. Horwitz, Changwei Wang, I. Ojima, 2018, Journal of natural products.

Coordination of Transcription Factors, NFY and C/EBP, in the Regulation of the mdrl b Promoter'

S. Horwitz, Lijian Yu, C. Yang, 1995 .

15 – Multidrug Resistance in the Mouse Macrophage-Like Cell Line J774.2

W. Mellado, L. Greenberger, S. Horwitz, 1988 .

Targeting protein translation in human non small cell lung cancer via combined MEK and mammalian target of rapamycin suppression.

R. Perez-soler, S. Horwitz, H. McDaid, 2007, Cancer research.

Upregulation of caveolin‐1 and caveolae organelles in Taxol‐resistant A549 cells

M. Lisanti, F. Galbiati, S. Horwitz, 1998, FEBS letters.

Posttranslational Modifications of Tubulin

Susan Band Horwitz, S. Horwitz, Suzan K. Chao, 2012 .

The interaction between mitotic checkpoint proteins, CENP-E and BubR1, is diminished in epothilone B-resistant A549 cells

A. Ikui, S. Horwitz, C. Yang, 2010, Cell cycle.

2-(m-Azidobenzoyl)taxol binds differentially to distinct β-tubulin isotypes

A. Fiser, S. Horwitz, Hui Xiao, 2016, Proceedings of the National Academy of Sciences.

TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas.

K. Odunsi, K. Eng, M. Dandapani, 2015, Gynecologic Oncology.

Taxol induces tyrosine phosphorylation of SHC and its association with GRB2 in murine raw 264.7 cells

M. Wolfson, S. Horwitz, C. Yang, 1997, International journal of cancer.

Hallmarks of Molecular Action of Microtubule Stabilizing Agents

V. Menon, R. Angeletti, A. Fiser, 2011, The Journal of Biological Chemistry.

Proteomics of Cancer Cell Lines Resistant to Microtubule-Stabilizing Agents

R. Angeletti, J. Albrethsen, S. Horwitz, 2013, Molecular Cancer Therapeutics.

Biochemical and genetic characterization of the multidrug resistance phenotype in murine macrophage-like J774.2 cells.

D. Cohen, L. Yu, L. Greenberger, 1992, Biochemical pharmacology.

Azidopine photoaffinity labeling of multidrug resistance-associated glycoproteins.

W. Mellado, S. Horwitz, C. Yang, 1988, Biochemical pharmacology.

Taxol mediates serine phosphorylation of the 66-kDa Shc isoform.

S. Horwitz, C. Yang, C. Yang, 2000, Cancer research.

Companion Diagnostics and Cancer Biomarkers Proteomics of Cancer Cell Lines Resistant to Microtubule-Stabilizing Agents

R. Angeletti, J. Albrethsen, C. Yang, 2013 .

Differential transport properties of two mdr gene products are distinguished by progesterone.

D. Cohen, L. Greenberger, S. Horwitz, 1990, The Journal of biological chemistry.